Search results
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 11 hours agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 4 days agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive developments in recent months ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 22 hours agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 days agoDo Vaccines Protect Against KP.3? Per Zambrano, all three COVID vaccine manufacturers—Pfizer,...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 4 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 5 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 6 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 3 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 15 hours agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...